Printed in U.S. A. inguinal lymph nodes were excised from mice and the tissues pressed through stainless steel mesh into Hank's balanced salt solution. The resulting cell suspension, composed mostly of lymphoid cells, was washed three times in normal saline, resuspended in 5 ml saline and injected intravenously into the ear vein of a white rabbit (weight about 2.5 kilograms). Between 5 X 10 and 1 X 10° cells were injected. A similar injection was given 14 days later. One week after the second injection, the rabbit was sacrificed by exposing him to a lethal dose of ether and the blood was collected by cardiac puncture. The blood was allowed to coagulate. The serum was removed, heated to 56°C for one-half hour, and absorbed with red blood cells from B-57 mice. The leukocyte-agglutination titer, using cells obtained from thymuses, was 1:512. No such agglutination occurred with serum from untreated rabbits.
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B-16 malignant melanoma was transplanted into 75 inbred mice of the C-Si strain. These mice were 2 weeks post-weaning. Transplantation was accomplished with minced melanoma in Eagle's minimum essential medium. The tumor was obtained from mice 14 days after transplantation. Three small tumor fragments (rice-grain size) were implanted subcutaneously into the right axilla of each mouse with a 13-gauge trochar. The mice were divided into 2 groups. Group I (40 mice) was studied for longevity after tumor transplantation. Group II (35 mice, of whom 31 survived 14 days) was autopsied at 14 days and examined for the presence of metastases. Half the mice of each group were injected subcutaneously with 0.3 ml anti-lymphocyte serum on days 0, 2, 4, 6 and 8 after transplantation.
In addition, a control group of 10 mice of identical ages as Groups I and II received the same amount of anti-lymphocyte serum but did not receive tumor transplants. alive at 36 days (Fig. 1) . All mice receiving only anti-lymphocyte serum were alive and seemingly well at 36 days.
During the first 40 days after transplantation the percentage of tumor takes in Group I was 100% in the 20 animals treated with serum and 85% in the 20 mice receiving transplantation alone (Table I) .
Group II, autopsied 14 days after transplantation, included 17 mice which had received serum plus transplants, and 14 which had received transplants alone. The average volume of the tumors in the sub-group receiving antilymphocyte serum was about 50% greater than that in the group not receiving serum (Table  II) . Furthermore, the percentage of animals with subcutaneous and internal metastases was greater in the group treated with antilymphocyte serum (Table III) . In the animals treated with serum, metastases were found in the parietal and visceral peritoneum in 65%, in the liver in 29%, in the diaphragm in 35%, and in the kidneys, ovaries and other organs in 24%. In contrast, no animal in the group receiving tumor transplants alone had metastases to internal organs. Table IV shows that the degree of metastases (arbitrarily indicated as 1+ to 4+ based on the number and size of metastatic loci) was higher in the group of mice treated with anti-lymphocyte serum than in the control group which did not receive the serum. The most likely explanation is that lymphocytes have some restraining iifluence on the growth of malignant melanomas and that this influence is diminished or abolished by the anti-lymphocyte serum. Although a number of possible mechanisms for the actions of anti lymphocyte serum has been proposed, the most attractive explanation is that it prevents the recognition of antigen by the lymphocytes (16, 17, 18) .
Further studies are needed to elucidate the component(s) present in anti-lymphocyte serum responsible for the effects observed. Finally, clarification is needed concerning the relationship, if any, between the increased tumor growth and metastases reported here and "tumor enhancement" (19) . In the latter phenomenon tumor growth is accelerated iii animals treated with serum obtained from tumor-bearing animals of the same species.
